Biotek Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.80 M
as on 16-11-2024
- Paid Up Capital ₹ 0.80 M
as on 16-11-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.45 Cr
as on 16-11-2024
- Revenue 22.46%
(FY 2023)
- Profit 27.70%
(FY 2023)
- Ebitda 1.07%
(FY 2023)
- Net Worth 15.18%
(FY 2023)
- Total Assets -1.66%
(FY 2023)
About Biotek Solutions
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.80 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹7.45 Cr.
Jajilkumar Parakkal, Abraham Jobin, Tomy Christhose, and One other member serve as directors at the Company.
- CIN/LLPIN
U33112KA2006PTC040501
- Company No.
040501
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biotek Solutions?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jajilkumar Parakkal  | Director | 14-Sep-2006 | Current |
| Abraham Jobin | Director | 14-Sep-2006 | Current |
| Tomy Christhose | Director | 14-Sep-2006 | Current |
| Robby Joseph | Director | 14-Sep-2006 | Current |
Financial Performance of Biotek Solutions.
Biotek Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.46% increase. The company also saw a substantial improvement in profitability, with a 27.7% increase in profit. The company's net worth Soared by an impressive increase of 15.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotek Solutions?
In 2023, Biotek Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Flyworld's Overseas Education Services Private LimitedActive 3 years 10 monthsRobby Joseph is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Jul 2021 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Mar 2021 | ₹3.52 M | Open |
Hdfc Bank Limited Creation Date: 25 Mar 2021 | ₹3.47 M | Open |
How Many Employees Work at Biotek Solutions?
Biotek Solutions has a workforce of 43 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotek Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotek Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
